Disease ID | Disease name | Source of annotation with CDC42 | OMIM link | Number of associated genes | genes |
---|---|---|---|---|---|
616737 | TAKENOUCHI-KOSAKI SYNDROME | ClinVar, OMIM | link to OMIM | 1 | CDC42 |
Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
Salmonella infection | hsa05132 | 6.29 |
Shigellosis | hsa05131 | 6.74 |
Pathogenic Escherichia coli infection | hsa05130 | 6.99 |
Pancreatic cancer | hsa05212 | 6.56 |
Renal cell carcinoma | hsa05211 | 6.6 |
Tight junction | hsa04530 | 5.53 |
Neurotrophin signaling pathway | hsa04722 | 5.78 |
Endocytosis | hsa04144 | 4.92 |
Focal adhesion | hsa04510 | 4.92 |
Chemokine signaling pathway | hsa04062 | 5.19 |
VEGF signaling pathway | hsa04370 | 6.77 |
Epithelial cell signaling in Helicobacter pylori infection | hsa05120 | 6.58 |
Bacterial invasion of epithelial cells | hsa05100 | 6.34 |
Proteoglycans in cancer | hsa05205 | 5.02 |
Pathways in cancer | hsa05200 | 3.98 |
Viral carcinogenesis | hsa05203 | 5.08 |
GnRH signaling pathway | hsa04912 | 6.18 |
Rap1 signaling pathway | hsa04015 | 4.97 |
Adherens junction | hsa04520 | 6.26 |
Fc gamma R-mediated phagocytosis | hsa04666 | 6.21 |
MAPK signaling pathway | hsa04010 | 4.63 |
Non-alcoholic fatty liver disease (NAFLD) | hsa04932 | 5.51 |
Regulation of actin cytoskeleton | hsa04810 | 4.9 |
T cell receptor signaling pathway | hsa04660 | 6.01 |
Ras signaling pathway | hsa04014 | 4.9 |
Leukocyte transendothelial migration | hsa04670 | 5.74 |
Axon guidance | hsa04360 | 5.63 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
DCC mediated attractive signaling | R-HSA-418885 | 9.18 |
Signaling by Robo receptor | R-HSA-376176 | 7.98 |
RHO GTPases Activate WASPs and WAVEs | R-HSA-5663213 | 7.85 |
Inactivation of Cdc42 and Rac | R-HSA-428543 | 9.81 |
GPVI-mediated activation cascade | R-HSA-114604 | 7.18 |
Immune System | R-HSA-168256 | 2.37 |
Signaling by Rho GTPases | R-HSA-194315 | 4.43 |
CDO in myogenesis | R-HSA-375170 | 8.12 |
Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.88 |
Adaptive Immune System | R-HSA-1280218 | 3.19 |
Developmental Biology | R-HSA-1266738 | 3.48 |
RHO GTPases activate PAKs | R-HSA-5627123 | 8.59 |
MAPK family signaling cascades | R-HSA-5683057 | 4.89 |
Signaling by VEGF | R-HSA-194138 | 4.66 |
Platelet activation, signaling and aggregation | R-HSA-76002 | 5.15 |
CD28 co-stimulation | R-HSA-389356 | 7.98 |
CD28 dependent Vav1 pathway | R-HSA-389359 | 9.4 |
Costimulation by the CD28 family | R-HSA-388841 | 6.56 |
Myogenesis | R-HSA-525793 | 8.12 |
RHO GTPases activate KTN1 | R-HSA-5625970 | 9.52 |
VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.7 |
RHO GTPases Activate Formins | R-HSA-5663220 | 6.01 |
Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.07 |
Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 5.23 |
G alpha (12/13) signalling events | R-HSA-416482 | 6.75 |
GPCR downstream signaling | R-HSA-388396 | 3.07 |
MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.54 |
Innate Immune System | R-HSA-168249 | 3.17 |
EPH-Ephrin signaling | R-HSA-2682334 | 6.43 |
Signaling by EGFR | R-HSA-177929 | 4.59 |
Sema4D in semaphorin signaling | R-HSA-400685 | 8.23 |
RHO GTPase Effectors | R-HSA-195258 | 4.94 |
Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 8.4 |
EGFR downregulation | R-HSA-182971 | 8.28 |
Signaling by GPCR | R-HSA-372790 | 2.68 |
EPHB-mediated forward signaling | R-HSA-3928662 | 7.62 |
Rho GTPase cycle | R-HSA-194840 | 6.04 |
RHO GTPases activate IQGAPs | R-HSA-5626467 | 8.34 |
Semaphorin interactions | R-HSA-373755 | 6.92 |
Axon guidance | R-HSA-422475 | 3.93 |
Hemostasis | R-HSA-109582 | 3.98 |
Signal Transduction | R-HSA-162582 | 1.78 |
Netrin-1 signaling | R-HSA-373752 | 7.59 |
GO term | GO ID | GO IC |
---|---|---|
purine ribonucleoside triphosphate binding | GO:0035639 | 2.22 |
enzyme binding | GO:0019899 | 2.27 |
Rho GDP-dissociation inhibitor binding | GO:0051022 | 8.35 |
GDP-dissociation inhibitor binding | GO:0051021 | 8.35 |
binding | GO:0005488 | 0.18 |
heterocyclic compound binding | GO:1901363 | 1.06 |
apolipoprotein A-I receptor binding | GO:0034191 | 8.35 |
apolipoprotein receptor binding | GO:0034190 | 7.79 |
ubiquitin-like protein transferase activity | GO:0019787 | 3.69 |
GTP-dependent protein binding | GO:0030742 | 6.91 |
mitogen-activated protein kinase kinase kinase binding | GO:0031435 | 6.85 |
pyrophosphatase activity | GO:0016462 | 3.04 |
ubiquitin protein ligase activity | GO:0061630 | 4.47 |
nucleotide binding | GO:0000166 | 1.96 |
guanyl ribonucleotide binding | GO:0032561 | 3.73 |
transferase activity | GO:0016740 | 1.95 |
purine nucleoside binding | GO:0001883 | 2.22 |
ribonucleoside binding | GO:0032549 | 2.22 |
purine nucleotide binding | GO:0017076 | 2.19 |
nucleoside binding | GO:0001882 | 2.21 |
identical protein binding | GO:0042802 | 2.63 |
GTP binding | GO:0005525 | 3.78 |
hydrolase activity | GO:0016787 | 1.9 |
GTPase activity | GO:0003924 | 4.31 |
nucleoside-triphosphatase activity | GO:0017111 | 3.09 |
nucleoside phosphate binding | GO:1901265 | 1.96 |
protein kinase binding | GO:0019901 | 3.44 |
catalytic activity | GO:0003824 | 1.05 |
ubiquitin-protein transferase activity | GO:0004842 | 3.73 |
ubiquitin-like protein ligase activity | GO:0061659 | 4.44 |
small molecule binding | GO:0036094 | 1.89 |
hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | GO:0016818 | 3.03 |
thioesterase binding | GO:0031996 | 7.25 |
kinase binding | GO:0019900 | 3.32 |
carbohydrate derivative binding | GO:0097367 | 2.03 |
organic cyclic compound binding | GO:0097159 | 1.05 |
hydrolase activity, acting on acid anhydrides | GO:0016817 | 3.03 |
guanyl nucleotide binding | GO:0019001 | 3.73 |
protein binding | GO:0005515 | 0.46 |
purine ribonucleotide binding | GO:0032555 | 2.2 |
receptor binding | GO:0005102 | 2.43 |
purine ribonucleoside binding | GO:0032550 | 2.22 |
ribonucleotide binding | GO:0032553 | 2.19 |